| Date | Time | Source | Headline | Symbol | Company |
| 11/03/2009 | 5:27AM | Marketwired | WallStSense.com Offers Detailed Analysis on ISRG, FWLT, INCY, CTRP, GLBL and FULT | NASDAQ:INCY | Incyte Corporation |
| 10/26/2009 | 5:17PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:INCY | Incyte Corporation |
| 10/23/2009 | 6:29AM | Marketwired | Global Market Perspective Review on FITB, INCY, CTRP, HBAN, FINL and DISH from TheFortuneFinancial.com | NASDAQ:INCY | Incyte Corporation |
| 10/20/2009 | 4:10PM | Business Wire | Incyte to Report Third Quarter 2009 Financial Results and Provide Update on Drug Discovery & Development Programs on November 5 | NASDAQ:INCY | Incyte Corporation |
| 10/16/2009 | 4:09PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:INCY | Incyte Corporation |
| 10/14/2009 | 6:35AM | Marketwired | RothmanResearch.com Stock Review for ONXX, INCY, AINV, CAKE, HCBK and JACK | NASDAQ:INCY | Incyte Corporation |
| 10/13/2009 | 3:01PM | Edgar (US Regulatory) | Schedule 13G | NASDAQ:INCY | Incyte Corporation |
| 10/05/2009 | 6:43AM | Marketwired | BenchmarkJournal.com Free Analyst Review for LPL, JAH, LRY, LEG, BX and INCY | NASDAQ:INCY | Incyte Corporation |
| 09/30/2009 | 6:00PM | Business Wire | Incyte to Present at the Fourth Annual JMP Securities Healthcare Focus Conference | NASDAQ:INCY | Incyte Corporation |
| 09/30/2009 | 4:29PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:INCY | Incyte Corporation |
| 09/30/2009 | 4:23PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 09/30/2009 | 4:05PM | Business Wire | Incyte Completes Offering of Convertible Senior Notes | NASDAQ:INCY | Incyte Corporation |
| 09/30/2009 | 4:05PM | Business Wire | Incyte Announces Closing of Public Offering of Common Stock | NASDAQ:INCY | Incyte Corporation |
| 09/28/2009 | 9:14PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 09/28/2009 | 9:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 09/28/2009 | 8:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 09/28/2009 | 8:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 09/28/2009 | 8:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:INCY | Incyte Corporation |
| 09/25/2009 | 3:24PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:INCY | Incyte Corporation |
| 09/25/2009 | 6:05AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 09/25/2009 | 6:04AM | Edgar (US Regulatory) | Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | NASDAQ:INCY | Incyte Corporation |
| 09/24/2009 | 7:29PM | Business Wire | Incyte Prices $350 Million Convertible Senior Notes Offering | NASDAQ:INCY | Incyte Corporation |
| 09/24/2009 | 7:27PM | Business Wire | Incyte Announces Pricing of Public Offering of 18,000,000 Shares of Common Stock | NASDAQ:INCY | Incyte Corporation |
| 09/23/2009 | 6:06AM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:INCY | Incyte Corporation |
| 09/22/2009 | 5:29PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:INCY | Incyte Corporation |
| 09/22/2009 | 4:41PM | Edgar (US Regulatory) | Registration of Additional Securities (up to 20%) (S-3MEF) | NASDAQ:INCY | Incyte Corporation |
| 09/22/2009 | 4:31PM | Business Wire | Incyte Announces Proposed Public Offering of 18,000,000 Shares of Common Stock | NASDAQ:INCY | Incyte Corporation |
| 09/22/2009 | 4:31PM | Business Wire | Incyte Announces Proposed Offering of $250 Million Convertible Senior Notes | NASDAQ:INCY | Incyte Corporation |
| 09/22/2009 | 6:23AM | Marketwired | AnalystChoice.com Brings You the Best Complimentary Research Report on DPTR, IACI, ALTR, GRMN, CTRP and INCY | NASDAQ:INCY | Incyte Corporation |
| 09/21/2009 | 9:03AM | Dow Jones News | Incyte Psoriasis Drug Effective In Early Trial; Shares Up | NASDAQ:INCY | Incyte Corp. |